维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="ScheuLen ME"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Tolllikereceptor 9 agonists as cancer therapeutics显示文摘	Holtick U Scheulen ME von Bergwelt-Baildon MS	2011	Expert Opin Investig Drugs2011，20，3：	1
2	The Ras-RafMEK-ERK pathway in the treatment of cancer显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Onkologie2002，25，6：	1
3	Phase 2 safety and activity trial of two dose levels of CCI-779 in women with previously treated locally advanced or metastatic cancer-Interim analysis显示文摘	Chan S Johnston SR Scheulen ME	2002	Breast Cancer Research and Treatment2002，76，1：	1
4	Phase Ⅱ study of nimotuzumab,a humanized monoclonal anti-epi- dermal growth factor receptor (EGFR) antibody in patients with locally advanced or metastatic pancreatic cancer显示文摘	Strumberg D Schuhheis B Scheulen ME	2012	Invest New Drugs2012，30，3：	1
5	The Ras-Raf-MEK-ERK pathway in the treatment of cancer 显示文摘	Hilger RA Scheulen ME Strmnberg D	2002	Oncology2002，25，6：	1
6	The Ras-Raf-MEK- ERK pathway in the treatment of cancer显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Onkologie2002，25，6：	1
7	Phase II study of temsirolimus ( CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or meta- static breast cancer 显示文摘	Chan S Scheulen ME Johnston S	2005	J Clin Oncol2005，23，23：	1
8	The Ras - Raf - MEK - ERK pathway in the treatment of cancer 显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Onkologie2002，25，6：	1
9	Toll-like receptor 9 agonists as cancer therapeutics 显示文摘	Holtick U Scheulen ME von Bergweh-Baildon MS	2011	Expert Opin InvestigDrugs2011，20，3：	1
10	The Ras-Raf-MEK-ERKpathway in the treatment of cancer显示文摘	Hilger RA ScheuLen ME Strumberg D	2002	Onkologie2002，25，6：	1
11	Toll-like receptor 9 agonists as cancer therapeutics显示文摘	Hohick U Scheulen ME yon Bergwelt-Baildon MS	2011	Expert Opin Investig Drugs2011，20，：	1
12	The Ras-Raf-MEK-ERK pathway in the treatment of cancer显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Onkologie2002，25，6：	1
13	The Ras-Raf_MEK、ERK pathway in the treatment of cancer显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Onkologie2002，25，6：	1
14	The Ras-Raf-MEK-ERK pathway in the treatment of cancer 显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Onkologle2002，25，6：	1
15	The Ras-Raf-MEK-ERK pathway In the treatment of cancer 显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Oncology2002，25，6：	1
16	Toll?like receptor 9 agonists as cancer therapeutics 显示文摘	Holtick U Scheulen ME von Bergwelt-Baildon MS	2011	Expert Opin Investig Drugs2011，20，3：	1
17	Phase Ⅱstudy of two dose levels of CCI-779 in locally advanced or metastatic breast cancer(MBC) failing prior anthracycline and/or taxane regimens显示文摘	CHAN S SCHEULEN ME JOHNSTON S	2005	J Clin Oncol2005，23，23：	1
18	Regorafenib (BAY 734506) in advanced colorectal cancer: a phase I study显示文摘	Stmmberg D Scheulen ME Schultheis B	2012	Br J Cancer2012，106，11：	1
19	The Ras-Raf-MEK-ERK pathway in the treatment of cancer 显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Onkologie2002，25，6：	1
20	The Ras-Raf-MEK-ERK pathway in the treatment of cancer显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Onkologie2002，25，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示